About CDMO Live Europe 2026
ICE Pharma was pleased to participate in CDMO Live Europe 2026 that took place at the Rotterdam World Trade Center from May 19th- 21st, 2026.
CDMO Live Europe is the premier event dedicated to BioPharma outsourcing excellence, bringing together pharmaceutical and biotech decision-makers to discuss external development and manufacturing strategies. This exclusive three-day event offers expert insights, curated networking opportunities, and strategic partnership building focused on small molecules, biologics, and cell & gene therapy.
Meet Our Team
Our CDMO services specialists and technical experts were available throughout CDMO Live Europe 2026 to discuss your contract manufacturing requirements and explore collaborative opportunities. Whether you were seeking support with finished dosage forms, API manufacturing, or integrated pharmaceutical solutions, we were on hand to help.
Experts Attended
- Daniele Maranza – Business Development Manager CDMO (d.maranza@icepharma.com)
Who We Are
ICE Pharma is a multinational company providing products and services to the pharmaceutical and healthcare markets.
Founded more than 70 years ago, we operate a network of manufacturing facilities and subsidiaries across North and South America, Europe, Asia, and Oceania. We serve customers in over 50 countries, commercializing our products and services in all major global markets.
As a key supplier to the pharmaceutical industry, we provide an extensive range of active pharmaceutical ingredients (APIs) including Ursodeoxycholic acid (UDCA) and Inosine Pranobex. Our portfolio also includes excipients, cell culture media for diagnostics, GMP intermediates, and research chemicals. Through our services business, we offer contract manufacturing for both solid and liquid finished dosage forms.
We also manufacture and commercialize branded products across the pharmaceutical, nutraceutical, and cosmetics markets.